Stem Cell Transplantation with Fludarabine and Melphalan Conditioning for Children with Acquired Bone Marrow Failure: A Nationwide Retrospective Study

被引：0
|
作者：
Yoshida, N. [1 ]
Yabe, H. [2 ]
Kudo, K. [3 ]
Kobayashi, R. [4 ]
Yabe, M. [2 ]
Inoue, M. [5 ,6 ]
Miki, M. [7 ]
Sakamaki, H. [8 ]
Kawa, K. [9 ]
Suzuki, R. [10 ]
Kato, K. [1 ]
Watanabe, K. -I. [11 ]
Kojima, S. [12 ]
机构：
[1] Japanese Red Cross Nagoya First Hosp, Childrens Med Ctr, Dept Hematol & Oncol, Nagoya, Aichi, Japan
[2] Tokai Univ, Sch Med, Dept Cell Transplantat & Regenerat Med, Isehara, Kanagawa 25911, Japan
[3] Fujita Hlth Univ, Sch Med, Dept Pediat, Toyoake, Aichi 47011, Japan
[4] Sapporo Hokuyu Hosp, Dept Pediat, Sapporo, Hokkaido, Japan
[5] Osaka Med Ctr, Dept Hematol Oncol, Izumi, Japan
[6] Res Inst Maternal & Child Hlth, Izumi, Japan
[7] Hiroshima Univ, Dept Pediat, Grad Sch Biomed Sci, Hiroshima, Japan
[8] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan
[9] Japanese Red Cross Kinki Block Blood Ctr, Ibaraki, Japan
[10] Nagoya Univ, Dept HSCT Data Management & Biostat, Grad Sch Med, Nagoya, Aichi 4648601, Japan
[11] Shizuoka Childrens Hosp, Div Hematol & Oncol, Shizuoka, Japan
[12] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi 4648601, Japan
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O151
引用
收藏
页码：S89 / S89
页数：1
相关论文
共 50 条
  • [21] Efficacy of fludarabine as immunosuppressor for bone marrow transplantation conditioning
    Terenzi, A
    Aversa, F
    Perruccio, K
    Aristei, C
    Chionne, F
    Latini, P
    Martelli, MF
    BLOOD, 1996, 88 (10) : 2373 - 2373
  • [22] Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Lymphoma
    Kekre, Natasha
    Marquez-Malaver, Francisco J.
    Cabrero, Monica
    Pinana, Jl
    Esquirol, Albert
    Soiffer, Robert J.
    Caballero, Dolores
    Terol, M. J.
    Martino, Rodrigo
    Antin, Joseph H.
    Lopez-Corral, L.
    Solano, Carlos
    Armand, Philippe
    Perez-Simon, Jose A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (10) : 1808 - 1815
  • [23] Fludarabine/melphalan conditioning for allogeneic stem cell transplantation (SCT) in elderly patients with AML/MDS
    Kennedy, GA
    Butler, J
    Durrant, S
    Hill, GR
    Western, R
    Morton, J
    BLOOD, 2005, 106 (11) : 438B - 439B
  • [24] Fludarabine, Busulfan and Melphalan Conditioning in Pediatric Myeloid Malignancies Undergoing Hematopoietic Stem Cell Transplantation
    Villegas, Mariflor S.
    Seo, Woon Li
    Chua, Hsin Chieh
    Thuan-Chong Quah
    Yeoh, Allen
    Tan, Poh-Lin
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S182 - S183
  • [25] ENCOURAGING RESULTS WITH THE USE OF FLUDARABINE BASED CONDITIONING REGIMENS IN CHILDREN WITH ACQUIRED AND CONGENITAL BONE MARROW FAILURE SYNDROMES (BMFS)
    George, B.
    Mathews, V
    Ahmed, R.
    Abraham, A.
    Srivastava, A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S231 - S231
  • [26] Favorable outcome for patients with myeloid disorders treated with fludarabine-melphalan reduced-intensity conditioning allogeneic bone marrow stem cell transplantation.
    Malladi, RK
    Peniket, AJ
    Norton, AE
    Samol, J
    Campbell, AJ
    Jones, J
    Keen-McGuire, A
    Littlewood, TJ
    BLOOD, 2003, 102 (11) : 469B - 469B
  • [27] Chimerism status after unrelated donor bone marrow transplantation with fludarabine-melphalan conditioning is affected by the melphalan dose and is predictive of relapse
    Imahashi, Nobuhiko
    Ohashi, Haruhiko
    Terakura, Seitaro
    Miyao, Kotaro
    Sakemura, Reona
    Kato, Tomonori
    Sawa, Masashi
    Yokohata, Emi
    Kurahashi, Shingo
    Ozawa, Yukiyasu
    Nishida, Tetsuya
    Kiyoi, Hitoshi
    Watamoto, Koichi
    Kohno, Akio
    Kasai, Masanobu
    Kato, Chiaki
    Iida, Hiroatsu
    Naoe, Tomoki
    Miyamura, Koichi
    Murata, Makoto
    ANNALS OF HEMATOLOGY, 2015, 94 (07) : 1139 - 1148
  • [28] Chimerism status after unrelated donor bone marrow transplantation with fludarabine-melphalan conditioning is affected by the melphalan dose and is predictive of relapse
    Sakemura, R.
    Imahashi, N.
    Ohashi, H.
    Terakura, S.
    Miyao, K.
    Kato, T.
    Sawa, M.
    Yokohata, E.
    Kurahashi, S.
    Ozawa, Y.
    Nishida, T.
    Kiyoi, H.
    Watamoto, K.
    Kohno, A.
    Kasai, M.
    Kato, C.
    Iida, H.
    Naoe, T.
    Miyamura, K.
    Murata, M.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S453 - S453
  • [29] Chimerism status after unrelated donor bone marrow transplantation with fludarabine-melphalan conditioning is affected by the melphalan dose and is predictive of relapse
    Nobuhiko Imahashi
    Haruhiko Ohashi
    Seitaro Terakura
    Kotaro Miyao
    Reona Sakemura
    Tomonori Kato
    Masashi Sawa
    Emi Yokohata
    Shingo Kurahashi
    Yukiyasu Ozawa
    Tetsuya Nishida
    Hitoshi Kiyoi
    Koichi Watamoto
    Akio Kohno
    Masanobu Kasai
    Chiaki Kato
    Hiroatsu Iida
    Tomoki Naoe
    Koichi Miyamura
    Makoto Murata
    Annals of Hematology, 2015, 94 : 1139 - 1148
  • [30] Disease-specific conditioning regimen in hematopoietic stem cell transplantation for children with inherited bone marrow failure syndromes
    Luo, C. J.
    Li, Q.
    Luo, C.
    Wang, J.
    Li, B.
    Chen, J.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S432 - S432
12345